NCT02076152 2021-07-30
FMISO PET Study of Glioblastoma
Massachusetts General Hospital
Phase NA Completed
Clinical Trials
11 trialsNCT01201850 2021-05-19
The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors
University of Colorado, Denver
Phase NA Terminated
NCT01280643 2021-03-15
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Fox Chase Cancer Center
Phase NA Terminated
NCT01063283 2019-11-18
AVF4759
University of Chicago
Phase NA Completed
NCT00499694 2018-06-12
Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
Barbara Ann Karmanos Cancer Institute
Phase NA Completed
NCT01223235 2018-06-12
Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00462501 2016-01-20
Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00675597 2015-11-20
Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00826800 2015-04-15
Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Terminated
NCT01017250 2014-02-28
Radiosurgery and Avastin for Recurrent Malignant Gliomas
Duke University
Phase NA Completed
NCT00121134 2013-12-24
Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
Dana-Farber Cancer Institute
Phase NA Completed